Pharmaceutical Commerce

Pharmaceutical Commerce

Pharmaceutical Commerce is a publication aimed at biopharma executives who make key business decisions. It highlights the processes and technologies that play a role in bringing approved drugs to market. Our editorial content is designed to enhance teamwork among management professionals, ultimately aiming to lower the costs associated with commercial operations.

National, Trade/B2B
English
Magazine

Outlet metrics

Domain Authority
52
Ranking

Global

#1895227

United States

#766329

Health/Biotechnology and Pharmaceuticals

#734

Traffic sources
Monthly visitors

Articles

  • 6 days ago | pharmaceuticalcommerce.com | Nicholas Saraceno

    In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.

  • 6 days ago | pharmaceuticalcommerce.com | Don Tracy

    Bringing Biotech Innovation Across BordersA feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets.

  • 1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

    PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this event. These days, it’s a year-round project—365 days. Once this year’s event wraps, I’ll be thanking our speakers and delegates and immediately starting research conversations for 2026. Before we even draft the agenda, we aim to conduct 150 to 200 hours of research calls.

  • 1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

    In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.

  • 1 week ago | pharmaceuticalcommerce.com | Don Tracy

    The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free biosimilar of Humira (adalimumab), across multiple inflammatory indications.

Pharmaceutical Commerce journalists

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations